deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02009800

ICI-VPH: Impact of HPV Immunisation Schedules Against HPV (ICI-VPH)

ICI-VPH: Impact Des Calendriers d'Immunisation Contre Les HPV

Sponsor: CHU de Quebec-Universite Laval

Conditions Human Papillomavirus Infections
Interventions Quadrivalent HPV vaccine
Updated 13 times since 2017 Last updated: Apr 21, 2022 Started: Nov 30, 2013 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Human Papillomavirus Infections, this trial is completed. The trial is conducted by CHU de Quebec-Universite Laval and has accumulated 13 data snapshots since 2013. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Mar 2017 · 59 days · monthly snapshot~Mar 2017 – ~Jul 2017 · 4 months · monthly snapshot~Jul 2017 – ~Apr 2018 · 9 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Mar 2020 · 19 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~May 2022 · 8 months · monthly snapshot~May 2022 – ~Jul 2024 · 26 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. May 2022 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  5. Sep 2021 — May 2022 [monthly]

    Active Not Recruiting PHASE3

▶ Show 8 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE3

  2. Mar 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  3. Aug 2018 — Mar 2020 [monthly]

    Active Not Recruiting PHASE3

  4. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE3

  5. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

  6. Jul 2017 — Apr 2018 [monthly]

    Active Not Recruiting PHASE3

  7. Mar 2017 — Jul 2017 [monthly]

    Active Not Recruiting PHASE3

    Status: Enrolling By Invitation → Active Not Recruiting

  8. Jan 2017 — Mar 2017 [monthly]

    Enrolling By Invitation PHASE3

    First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CHU de Quebec-Universite Laval
  • Centre hospitalier de l'Université de Montréal (CHUM)
  • Institut National en Santé Publique du Québec
  • Ministere de la Sante et des Services Sociaux
Data source: CHU de Quebec-Universite Laval

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations